|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2021
vol. 123 abstract:
Case report
Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases
Małgorzata Rogaczewska
1
,
Marcin Stopa
1
1.
Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2021, 123, 1: 42–45
Online publish date: 2021/03/31
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
We present a report of two patients with active ocular toxoplasmosis treated with intravitreal clindamycin. The location of the retinochoroiditis close to the optic disc validated the injection of 1 mg clindamycin, even though the visual acuity was not diminished. After 7 days, inflammatory lesions and vitritis regressed significantly. Moreover, no side effects occurred.
keywords:
Toxoplasma gondii, clindamycin, intravitreal injection, toxoplasmic retinochoroiditis |
|
POLSKI
